You just read:

Lancet Publication: New Analysis Demonstrates Only Small Minority of Severe/Very Severe COPD Patients May Benefit from Adding ICS to SPIRIVA® HANDIHALER® (tiotropium bromide inhalation powder) + LABA Therapy

News provided by

Boehringer Ingelheim

Apr 08, 2016, 07:00 ET